Sagimet Biosciences Inc. (SGMT) stock
SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$9.85−0.28 (-2.76%)
Close on Nov 17, 2026Market cap $612.26MP/E –Yield –
Sagimet Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Sagimet Biosciences
Sagimet Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?